The vaccine, known as CoronaVac, is still in phase 3 clinical trials in Brazil and has not been registered for wider use in Brazil, Anvisa said.
Brazil health auth. OKs import of 6 mln doses of Chinese COVID-19 vaccine
By REUTERS
01/15/2025 04:46 PM
By REUTERS
01/15/2025 04:11 PM
By REUTERS
01/15/2025 02:37 PM
By REUTERS
01/15/2025 02:34 PM
By REUTERS
01/15/2025 02:04 PM
By REUTERS
01/15/2025 01:52 PM
By REUTERS
01/15/2025 01:04 PM
By REUTERS
01/15/2025 06:31 AM
By REUTERS
01/15/2025 03:51 AM